MMTEC (MTC) had the highest return on March 1, 2024 by a US stock in the Nasdaq Composite (IXIC), returning 50.6%.

ASSET	DATE	% RETURN
MMTEC (MTC)	3/1/2024	50.59%
Roma Green Finance Limited Ordinary Shares (ROMA)	3/1/2024	47.83%
Jaguar Animal Health (JAGX)	3/1/2024	45.9%
Cardiff Oncology (CRDF)	3/1/2024	45.5%
Envoy Medical (COCH)	3/1/2024	32.7%
TheRealReal (REAL)	3/1/2024	27.78%
Solarmax Technology Inc Common Stock (SMXT)	3/1/2024	23.86%
BioLife Solutions (BLFS)	3/1/2024	23.51%
Plug Power (PLUG)	3/1/2024	21.94%
PTC Therapeutics (PTCT)	3/1/2024	20.57%
Expensify (EXFY)	3/1/2024	20.29%
Regenxbio (RGNX)	3/1/2024	18.65%
Benitec Biopharma Ltd ADR (BNTC)	3/1/2024	18.57%
NRX Pharmaceuticals (NRXP)	3/1/2024	18.38%
Swvl (SWVL)	3/1/2024	18.28%
Quanterix (QTRX)	3/1/2024	17.7%
Solowin Holdings Ordinary Share (SWIN)	3/1/2024	17.54%
Lexaria Bioscience (LEXX)	3/1/2024	17.27%
BioNexus Gene Lab Corp Common stock (BGLC)	3/1/2024	17.21%
Entero Therapeutics (ENTO)	3/1/2024	17.11%
Garden Stage Limited Ordinary Shares (GSIW)	3/1/2024	17.03%
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI)	3/1/2024	16.84%
Conifer (CNFR)	3/1/2024	16.83%
Olema Pharmaceuticals (OLMA)	3/1/2024	16.63%
Monopar Therapeutics (MNPR)	3/1/2024	16.51%